Large differencies in age-specific survival in multiple myeloma in the nordic countries

Blood Cancer J. 2024 Mar 11;14(1):43. doi: 10.1038/s41408-024-01026-6.

Kari Hemminki^{1

2}, Frantisek Zitricky³, Asta Försti^{4

5}, Raija Silvennoinen⁶, Annette Vangsted⁷, Markus Hansson^{8

9}

¹ Biomedical Center, Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605, Pilsen, Czech Republic. K.Hemminki@dkfz.de.
² Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany. K.Hemminki@dkfz.de.
³ Biomedical Center, Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605, Pilsen, Czech Republic.
⁴ Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
⁵ Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
⁶ Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, & University of Helsinki, Helsinki, Finland.
⁷ Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
⁸ Department of Internal Medicine and Clinical Nutrition, Sahlgrenska University Hospital/Sahlgrenska Academy, Bruna stråket 5 plan 5, 41325, Göteborg, Sweden.
⁹ Hematology and Transfusion Medicine, Department of Laboratory Medicine, BMC B13, 221 84, Lund, Sweden.

No abstract available

Publication types